Consideration of QT/QTc Interval Data in a Phase I Study in Patients with Advanced Cancer

We commend the effort of these authors to undertake and report on their analysis of the QT/QTc interval during their phase I evaluation of combretastatin A4 phosphate and also for their inclusion of these data in this publication [(1)][1] . Capturing and interpreting such data can be challenging,